Sommaire

Numéro précédent | Numéro suivant

• • ·Editorial board

    Page :A9

    
• • ·Table of contents

    Page :A12

    
• • ·Information for readers

    Page :A34

    
• • ·JAAD Case Reports article list

    Page :A37

    
• • ·Journal based CME instructions and information

    Page :A42

    

• Continuing Medical Education

  • ·Disability and the dermatology patient—part 1: Improving access to dermatologic care

    Page :765-774

    Sonal Muzumdar, Sarah Kamsiah Zemlok, Brett Sloan, Robert Krug, Mary Wu Chang

    Résumé Résumé Plan Plan  
  • ·CME examination

    Page :775

    
  • ·Answers to CME examination

    Page :776

    
  • ·Disability and the dermatology patient- part 2: Supporting patients with disabilities

    Page :777-789

    Sarah Kamsiah Zemlok, Sonal Muzumdar, Mary Wu Chang, Robert Krug, Brett Sloan

    Résumé Résumé Plan Plan
  • ·CME examination

    Page :790-791

    
  • ·Answers to CME examination

    Page :792

    

• Letter from the Editor

  • ·Letter from the Editor: Published reviews

    Page :793-794

    Dirk M. Elston

    

• This Month in JAAD

  • ·This month in JAAD: March 2026

    Page :795

    Dirk M. Elston

    

• Highlights from JAAD Case Reports

  • ·Highlights from JAAD case reports: March 2026

    Page :796

    Abby Susan Van Voorhees

    

• Highlights from JAAD International

  • ·Highlights from JAAD International: March 2026

    Page :797

    Jonathan Kantor

    

• Highlights from JAAD Reviews

  • ·Invisible barriers, visible consequences: Skin cancer disparities in intellectual disability

    Page :798-799

    Shari R. Lipner

    

• A Clinician's Perspective

  • ·Artificial intelligence in dermatology: A matter of trust

    Page :800-801

    Warren R. Heymann

    

• Original Articles

  • ·Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitors

    Page :802-809

    Andrew Blauvelt, Bruce E. Strober, Guy S. Eakin, Leah McCormick Howard, Christy Langan, Peter C.M. van de Kerkhof, Lluís Puig, Mark G. Lebwohl, Ricardo Romiti, April W. Armstrong, Siew Eng Choon, Ravi Ramessur, Joel M. Gelfand, Joseph F. Merola, Kevin L. Winthrop, Tiago Torres

    Résumé Résumé Plan Plan
  • ·Tolerability and efficacy of unorthodox dosing regimens of tofacitinib and baricitinib in pediatric patients with moderate to severe alopecia areata

    Page :810-818

    Mei Wan, Min Zhang, Xiao Song, Nanlan Yu, Sisi Deng, Cunjian Zhou, Tianxing Hu, Zhiqiang Song, Xichuan Yang

    Résumé Résumé Plan Plan  

• JAAD Game Changers

  • ·JAAD Game Changer: Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study

    Page :818

    Craig Fisher, Wendi E. Wohltmann

    

• Original Articles

  • ·In vivo cutaneous confocal microscopy for diagnosing the lentigo maligna spectrum: A multicentre prospective study and proposal of a lentigo maligna spectrum score

    Page :819-827

    Bruna Melhoranse Gouveia, Terence Wong, Peter M. Ferguson, Amanda Glanz, Genevieve Ho, Christoph Sinz, Helena Collgros, Linda K. Martin, Rodrigo Schwartz, Mary-Ann Sharouni, Constanza Ramirez, Maria Paula Senna Santos, Bruna Gallo, Richard A. Scolyer, Anne E. Cust, Serigne N. Lo, Pascale Guitera

    Résumé Résumé Plan Plan  

• JAAD Game Changers

  • ·JAAD Game Changer: Excision margins for melanoma in situ on the head and neck—A single-center 10-year retrospective review of treatment with Mohs micrographic surgery

    Page :827

    Craig Fisher, Wendi E. Wohltmann

    

• Original Articles

  • ·Decreased risk of cardiovascular disease in dermatology patients taking niacinamide: A TriNetX cohort study

    Page :828-834

    Yousef Salem, Mahnoor Liaqat, Nadeen Gonna, Dina Zamil, Ferris Abu-Ghosh, Anwar Merie, Dimitri Cassimatis, Ida Orengo

    Résumé Résumé Plan Plan  
  • ·Ultraviolet-induced fluorescent dermoscopy for the diagnosis of skin tumors: A multicenter study

    Page :835-842

    Cristian Navarrete-Dechent, Pawel Pietkiewicz, Alvaro Abarzua-Araya, Rosario Agüero, Stephen W. Dusza, Julien Anriot, Pablo Vargas-Mora, Javiera Garcés, Sofía Villagrán, Sergio Bustos, Sebastián González-Valdés, Samuel Ibañez, Manuela Boleira, Natalia Jaimes, David Swanson, Leonel Hidalgo, Katherine Droppelmann, Consuelo Cardenas, Pablo Uribe, Ashfaq A. Marghoob

    Résumé Résumé Plan Plan  
  • ·Development of a gene-expression panel predictive of local recurrence, metastasis, and overall survival in intermediate- to high-risk cutaneous squamous cell carcinoma: A cohort study

    Page :843-851

    Zachary Leibovit-Reiben, Alyssa Stockard, Shams Nassir, Miranda Yousif, Xing Li, Kevin J. Severson, Alysia Hughes, Jacob Kechter, Angelina Hwang, Blake Boudreaux, Puneet Bhullar, Nan Zhang, Richard J. Butterfield, Tao Ma, Cristian David Cardona-Machado, Manuel Jesús Pérez-Baena, Collin M. Costello, Steven A. Nelson, David J. DiCaudo, Christian L. Baum, Mark R. Pittelkow, Javier Cañueto, Aaron R. Mangold

    Résumé Résumé Plan Plan  
  • ·Population differences in Merkel cell carcinoma by virus status and anatomic site: A multi-cohort analysis including institutional, SEER, and NCDB data

    Page :852-858

    Mackenzie R. Martin, Serena M. Vilasi, Yoshine Saito, Noreen Mohsin, Jordan E. Jarvis, Patrick Hallaert, Danielle J. Reed, Lingling Miao, Jacob T. Tribble, Elizabeth K. Cahoon, Ruth M. Pfeiffer, Krista Lachance, Rima Kulikauskas, Paul Nghiem, Isaac Brownell

    Résumé Résumé Plan Plan  
  • ·A single-arm phase 2 study of talimogene laherparepvec in patients with lower-risk invasive cutaneous squamous cell cancer

    Page :859-866

    Delaney Bake Stratton, Anngela Christina Adams, Srinath Sundararajan, Haiyan Cui, Denise J. Roe, Clara Curiel-Lewandrowski

    Résumé Résumé Plan Plan  
  • ·Bimekizumab demonstrated a favorable safety profile and high levels of efficacy with up to 2 years of treatment in patients with moderate to severe hidradenitis suppurativa: Pooled results from two phase 3 randomized, controlled trials and their open-label extension

    Page :867-878

    Christopher J. Sayed, Brian Kirby, Amit Garg, Haley B. Naik, Alexa B. Kimball, Christos C. Zouboulis, Gregor B.E. Jemec, Georgios Kokolakis, John R. Ingram, Akimichi Morita, Delphine Deherder, Christina Crater, Robert L. Rolleri, Tom Vaux, Jérémy Lambert, Bartosz Lukowski, Falk G. Bechara

    Résumé Résumé Plan Plan  
  • ·Efficacy and safety of ruxolitinib cream in patients with mild to moderate hidradenitis suppurativa: Results from a randomized, double-blind, vehicle-controlled phase 2 study

    Page :879-887

    Martina L. Porter, M. Celeste Ferreira-Cornwell, Mingyue Wang, Haq Nawaz, Melinda J. Gooderham

    Résumé Résumé Plan Plan  
  • ·Efficacy of dupilumab for the treatment of moderate-to-severe chronic hepatic pruritus: An open-label, single-arm, exploratory study

    Page :888-894

    Lorna A. Evans, Andrew P. Keaveny, Denise M. Harnois, Michael G. Heckman, Hanna J. Sledge, Jason C. Sluzevich

    Résumé Résumé Plan Plan  

• Clinical Reviews

  • ·Biologic therapies for dermatologic emergencies: A comprehensive review

    Page :895-902

    Nina Modanlo, Kyle Cheng, Michael O. Nguyen, Amanda Truong

    Résumé Résumé Plan Plan
  • ·Incontinence-associated dermatitis: Not just babies

    Page :903-913

    Kennedy Sparling, Ilona J. Frieden, Daniel C. Butler

    Résumé Résumé Plan Plan  
  • ·Management of cutaneous squamous cell carcinoma: A literature review and update

    Page :914-923

    Megan H. Trager, Emily R. Gordon, Alyssa Breneman, Tessa LeWitt, Brian Cahn, Murad Alam, Elizabeth M. Billingsley, Karen L. Connolly, Kishwer S. Nehal, Allison Vidimos, Faramarz H. Samie

    Résumé Résumé Plan Plan

• Brief Reports

  • ·Evaluating immune-related adverse events associated with the novel lymphocyte activation gene 3 inhibitor relatlimab in combination treatment of malignant melanoma: A retrospective comparative pharmacovigilance analysis of the Food and Drug Administration adverse events reporting system database

    Page :924-926

    Gaurav N. Pathak, Amar D. Desai, Faramarz H. Samie

    
  • ·Real-world efficacy and safety of ritlecitinib combined with phototherapy in refractory vitiligo: A single-center experience

    Page :926-928

    Li Zhang, Luyan Tang, Jun Zhou, Jian Li

    
  • ·Medicare data analysis of complex versus intermediate repairs following Mohs micrographic surgery in Arizona, 2018-2021

    Page :928-930

    Aleksi Hendricks, Jeffrey Krase, Jason DuPont

     
  • ·Postoperative radiotherapy and overall survival in head and neck Merkel cell carcinoma: A population-based cohort study using the Surveillance, Epidemiology, and End Results database (2004-2021)

    Page :930-933

    Yuan Zheng, Di Zhang, Qihao Sun, Jiaoyang Lu

     
  • ·Clinical evaluation of a postoperative prolonged-course dose-escalation superficial radiotherapy regimen for keloid treatment: A prospective observational study

    Page :933-936

    Yifan Xie, Chengbei Bao, Chao Ji, Songyu Wang, Fang Fang, Qiuyun Xu, Mengting Lin, Shuyi Shen, Jiawen Chen, Zequn Tong, Jian Liu, Dan Deng, Ting Gong

    
  • ·International multicenter case series of gestational dupilumab exposure in the treatment of atopic dermatitis: Maternal complications and fetal outcomes

    Page :936-940

    Ajay S. Dulai, Emi M. Murase, Gianluca Avallone, Silvia Mariel Ferrucci, Angelo Valerio Marzano, Simone Ribero, Michael Ardern-Jones, Emily Ko, Carsten Flohr, Yael Anne Leshem, Mette Deleuran, Christian Vestergaard, DirkJan Hijnen, Juliëtte Bras, Scott A. Elman, Sara Pruneddu, Daniel Butler, Raj Chovatiya, Giampiero Girolomoni, Alexandra K. Golant, Marijke Kamsteeg, Paula C. Luna, Dedee F. Murrell, Madeleine Stark, Tiago Torres, Elif Afacan Yildrim, Selim Aractingi, Christine Bangert, Rebecca Batchelor, Kuan-Yu Chen, Alan D. Irvine, Jenna J. Lullo, Linda K. Martin, Julia-Tatjana Maul, Bibiana Pérez, David Rosmarin, Jane E. Sansom, Brittney Schultz, Alexa Shipman, Nanette B. Silverberg, Zsuzsanna Szalai, Annamária Fodor, Anber Ancel Tanaka, Kate Viola, Raja K. Sivamani, Jenny E. Murase

     
  • ·Practice characteristics of Veterans Affairs-affiliated dermatologists in the United States: A national comparative study

    Page :940-942

    Stephanie Humen, Seda Sahin, Christian Gronbeck, Eric Beltrami, Brett Sloan, Hao Feng

     
  • ·Post-market surveillance data demonstrate high mortality associated with enfortumab vedotin skin toxicity, not worsened by immune checkpoint inhibitors or corticosteroids

    Page :942-944

    Mackenzie M. Kilton, Erin X. Wei, Corey J. Georgeson, Jesse P. Hirner

     
  • ·Utilization of Mohs micrographic surgery for acral lentiginous melanoma: A retrospective cohort study of the National Cancer Database (NCDB) 2004-2022

    Page :944-946

    Akshay Pulavarty, Derek Maas, Richard Li, Michelle C. Juarez, Nayoung Lee, Mary L. Stevenson, Ann Y. Lee, John A. Carucci, Maressa C. Criscito

    
  • ·Pigmented lesion accuracy by ChatGPT in diagnosis of dermoscopic images

    Page :946-947

    Isha Gandhi, Robert Adler, William Villasi, Nawang Singhe, Manan Mehta, Emily Cowen, Katerina Svigos, Justin W. Marson, Jessica L. Feig

    
  • ·Differences in rates of prescription for biologic therapy between Hispanic, non-Hispanic White, and non-Hispanic minority psoriasis patients: A cross-sectional study of the Medical Expenditure Panel Survey, 2014-2022

    Page :947-950

    Alina S. Feng, Wilson Liao

    
  • ·Characteristics of youth utilizing pediatric dermatology: A cross-sectional PEDSnet study

    Page :950-953

    Molly Thapar, Briana Kille, Josh Tucker, Sarah J. Schmiege, Elizabeth Garcia-Creighton, Markus D. Boos, Esteban Fernández Faith, Amy S. Paller, Dawn H. Siegel, Liza H. Siegel, Roslyn T. Varki, Albert Yan, Lucinda L. Kohn

    
  • ·Improving isotretinoin adherence through a patient navigator: A pilot study in a safety net population

    Page :953-955

    Yanel Hernandez, Krittin Supapannachart, Tina Chang, Daniel Klufas, Sarah Coates, Aileen Y. Chang, Erin H. Amerson

    
  • ·Topical tacrolimus for superficial tufted angioma: A randomized clinical trial

    Page :956-958

    Jiangyuan Zhou, Xue Gong, Min Yang, Zixin Zhang, Tong Qiu, Yuru Lan, Xuepeng Zhang, Congxia Yang, Zilong Zhou, Yujia Zhang, Kaizhi Zhang, Chunshui He, Qiang Peng, Fang Hou, Fan Hu, Chunchao Xia, Wei Shan, Pingqian Bao, Siyuan Chen, Yi Ji

    
  • ·Five-year real-world drug survival of dupilumab in patients with atopic dermatitis: A multicenter retrospective study

    Page :958-960

    Siddhartha Sood, Ahmed Bagit, Khalad Maliyar, Jorge R. Georgakopoulos, Brian D. Rankin, Abrahim Abduelmula, Fernejoy Leung, Vimal H. Prajapati, Jensen Yeung

     
  • ·Eggshell fragments as a high-yield diagnostic target in microscopic examination of scabies: A retrospective study

    Page :960-962

    Chuang Gao, Chaoshuai Zhao, Zhiwei Zhang, Zhouwei Wu

     
  • ·Surgical treatment of temporal triangular alopecia using follicular unit excision and implantation coverage value: A case series

    Page :962-963

    Roberto Vieira, Janaina Vieira

     
  • ·Public perceptions on the medical versus cosmetic nature of dermatologic conditions

    Page :963-965

    Aliya Shabbir, Avery H. LaChance, John S. Barbieri

     
  • ·Reflectance confocal microscopy analysis of epidermolysis bullosa nevi – A cross-sectional study

    Page :966-968

    Chan I. Thien, Zilda N.P. de Oliveira, Luciana P. Samorano, Maria Cecília Rivitti-Machado, Lílian K.F.L. Rocha

    Plan Plan  
  • ·Tocilizumab for refractory and/or relapsing polyarteritis nodosa

    Page :968-970

    Adrien Cottu, Chloé Grolleau, Camille Gandon, Thibault Mahévas, Clémence Lepelletier, Florence Cordoliani, Anne Contis, Estibaliz Lazaro, Cédric Léonard, Raluca Sterpu, Patricia Senet, Achilla Aouba, Emmanuelle Weber, Cécile Morice, Emma Huard, Adrien Sanchez, Nicolas Limal, Thibault Maillet, Benjamin Terrier, Maxime Battistella, Jean-David Bouaziz, Marie Jachiet

     
  • ·Disparities in melanoma survival in Asian American and Pacific Islander patients: A Surveillance, Epidemiology, and End Results (SEER) program-based analysis

    Page :970-972

    Christopher G. O'Neill, Lauren S. Fane, Angela H. Wei, Raghav Tripathi, Jeremy S. Bordeaux, Iris Y. Sheng

    Plan Plan  
  • ·The impact of GLP-1 receptor agonists on clinical outcomes and healthcare utilization in hidradenitis suppurativa patients: A retrospective cohort study using TriNetX

    Page :972-974

    Jack Fite, Alison M. Treichel, Thomas S. McCormick, Neil Korman, Kevin D. Cooper

    
  • ·Patient-reported psychological impact of cosmetic procedure complications

    Page :974-976

    Kathleen M. Coerdt, Taryn N. Murray, Stephanie T. Le, Olga Kruglinskaya, Evan A. Rieder, Paul M. Friedman

     
  • ·AI-assisted dermatologic diagnosis using a large language model

    Page :976-978

    Frédéric Dezoteux, Marie Boileau, Clément Pruvot, Manon Dubois, Baptiste Mille, Henry Abi Rached, Olivier Philip, Marie Véron, Carla Fassanaro, Guillaume Delzenne, Olivier Carpentier, Sébastien Buche, Jean Matthieu L'Orphelin, Antoine Bertolotti, Raphaël Bentegeac, Aghiles Hamroun, Bastien Le Guellec

     
  • ·Utility of 31-gene expression profile for American Joint Commission on Cancer pT1a melanomas

    Page :978-979

    Tejas P. Joshi, Rishabh Lohray, Ida F. Orengo

    
  • ·Combined impact of lesion and itch severity on initiation of biologic treatment in patients with moderate or severe atopic dermatitis from specialty dermatology facilities in the United States

    Page :979-982

    Gil Yosipovitch, Matthew Zirwas, Lawrence Rasouliyan, Amanda G. Althoff, Danae A. Black, Olivier Chambenoit, Lorenzo Sabatelli, Peter Lio

     
  • ·ELISA-detected salivary Treponema pallidum antibodies for predicting neurosyphilis risk: A retrospective multicenter cohort study

    Page :983-984

    Wei-Peng Lin, Ling Yang, Ze-Jun Luo, Jia-Hui Shen, Zu-Ping Song, An-Ni Lin, Yu-Zhen Chen, Jia-Wen Wei, Krishna Hamal, Ming Liang, Di Yang, Sichan Wu, Xueying Zhong, Zhenwu Yuan, Yuyang Jiang, Xiaomei Luo, Dong-Hua Liu

     
  • ·Identifying high-risk subtypes and risk factors for recurrence in Merkel cell carcinoma: A single-institution retrospective study

    Page :984-986

    Yingjoy Li, Kenneth G. Linden, James G. Jakowatz, Maki Yamamoto, Thuy B. Tran

    
  • ·Risk of pediatric infections following dupilumab treatment for atopic dermatitis: A TriNetX cohort study

    Page :986-988

    Henry O. Herrera, Jeremy S. Bordeaux

    
  • ·Artificial intelligence-driven comparative efficacy of topical crisaborole versus halometasone for vitiligo: A randomized and noninferiority study

    Page :989-990

    Meng Wang, Jiayi Sun, Tianyu Wang, Zhenhua Yue, Guoyan Liu, Xiaoxiao Yan, Yonghu Sun, Furen Zhang

     
  • ·Demographic trends for fellows in Mohs surgery and dermatopathology: A cross-sectional analysis of 2010-2024

    Page :990-993

    Albert E. Zhou, Yee Won Kim, Hao Feng

    Plan Plan  
  • ·Early dermoscopic and confocal features predict response to topical ruxolitinib in nonsegmental vitiligo: A prospective observational study

    Page :993-995

    Helena Gioacchini, Giulia Veronesi, Federico Venturi, Emanuela Martina, Aldo Gardini, Tommaso Bianchelli, Giovanni Marco D'Agostino, Agnese Rossi, Emi Dika, Anna Campanati

     
  • ·Risk of immunogenicity during infliximab therapy in hidradenitis suppurativa compared with other chronic inflammatory diseases: A retrospective monocentric cohort

    Page :995-998

    Camille Barral, Ramatoulaye Ndiaye, Christina Bergqvist, Sophie Hue, Pierre Wolkenstein, Mathieu Uzzan, Pascal Claudepierre, Emilie Sbidian, Quentin Beytout

     
  • ·Beyond the surface: Histopathologic inflammation persists in many patients with clinically quiescent primary cicatricial alopecia

    Page :998-1000

    Anna Brinks, Carli Needle, Kaitlyn Yin, Caitlin Kearney, Alexandra Flamm, Adam I. Rubin, Ata S. Moshiri, Prince Adotama, Lidia Rudnicka, Joanna Czuwara, Jerry Shapiro, Michael Occidental, Kristen Lo Sicco

    
  • ·Biologic therapy for generalized pustular psoriasis: Real-world comparative effectiveness in a single-center

    Page :1000-1003

    Zhongrui Xu, Jiaqi Wang, Yibo Wei, Zhiguo Li, Yaxing Bai, Gang Wang, Shuai Shao

     
  • ·Characterization of the spectrum of cutaneous adverse reactions to enfortumab vedotin: A retrospective cohort study

    Page :1003-1006

    Han Li, Arthur M. Samia, Kiran Motaparthi

    
  • ·The impact of apremilast on cardiometabolic and inflammation indexes in psoriatic patients at high cardiovascular risk: A real-world multicenter retrospective observational study

    Page :1006-1008

    Annunziata Raimondo, Matteo Megna, Marianna Donnarumma, Serena Lembo, Maria Maddalena Nicoletti, Francesca Romano, Oriele Sarno, Genoveffa Scotto Di Luzio, Anna Balato

     
  • ·Disparities in immunotherapy treatment for mycosis fungoides and Sézary syndrome in the National Cancer Database

    Page :1008-1010

    Bryan L. Peacker, Beatrix B. Thompson, Sara Behbahani, Sydney Corey, Natalie Braun, Natalie M. Baker, Ghida El-Banna, Salvia Jain, Jeffrey Barnes, Chirayu Patel, Kevin Sheng-Kai Ma, Steven T. Chen

    
  • ·Training backgrounds and demographic trends of academic leadership in dermatology: A cross-sectional analysis of editorial leadership, residency program directors, and department chairs

    Page :1010-1013

    Charles B. Lau, Dhruv Manik, Gideon P. Smith

    
  • ·Bullous pemphigoid and its association with neural diseases: A propensity matched retrospective study

    Page :1013-1015

    Rehman Basharat, Javed Iqbal

     
  • ·Diagnostic yield of biopsy in cutaneous polyarteritis nodosa: A retrospective cohort study from 2 academic centers

    Page :1015-1017

    Nikki Zangenah, Arjun Mahajan, Evan W. Piette

    
  • ·Chemoprophylactic effect of PD-1/PD-L1 inhibitor treatment on non-melanoma skin cancer development

    Page :1017-1019

    Justine Schneider, Jordan Hill, Vamsi Varra, Alba Posligua, Claire F. Verschraegen, Kathryn T. Shahwan, David R. Carr

    
  • ·Pruritic papules in systemic sclerosis is associated with scleroderma renal crisis

    Page :1019-1021

    Junxia Huang, Xiuyuan Wang, Xue Han, Manna Lin, Ji Yang

     
  • ·Clinical assessment implications from core outcome domain set development exercises in dermatology

    Page :1021-1023

    Zachary Ney, Dallin Ringwood, Meg Takara, Zachary Frost, Mark Conley, Jacob Kean, Aaron M. Secrest, Kristina Callis Duffin, Zachary H. Hopkins

    
  • ·Association between endometriosis and atopic dermatitis: Evidence from NHANES and genetic causal inference

    Page :1023-1026

    Yingying Dai, Yuanting Wang, Hongjie Luo, Jing Tan, Xian Jiang

    
  • ·No serum estradiol changes with 5-alpha reductase inhibitors for late alopecia in cancer survivors: A retrospective cohort study

    Page :1026-1028

    Michael M. Ong, Lavanya Mittal, Mario Lacouture, Stephen Dusza, Allison Gordon, Jacqueline F. Bromberg, Shari B. Goldfarb, Neil M. Iyengar, Kara Long Roche, Alina Markova

    
  • ·An analysis of dermatology match statistics and other metrics of competitiveness

    Page :1028-1030

    Emma McIntyre, Tiffany R. Wong, Mildred Min, Kishore M. Bharadwaj, Erik-Matthew Sario, Bhagvat Maheta, Victor Huang, Michael S. Wong

     

• Health Policy & Practice

  • ·Prior authorization denials lack transparency and accountability

    Page :1031-1033

    Sherry Ershadi, Ana B.W. Greenberg, Samara Katini, John S. Barbieri, Jeffrey M. Cohen

    
  • ·Current landscape of AI Regulation in Dermatology

    Page :1034-1035

    Mateen Motavaf, Danyal Raza, William Frye, Melodi Javid Whitley

     

• Humanities

  • ·Enduring professional societies as a remedy for burnout: How the American Dermatological Association fosters connection, resilience, and renewal

    Page :1036-1037

    Joshua R. Jennings, Thomas Helm, Robert T. Brodell

     

• Ethics Journal Club

  • ·The ethical responsibilities and implications of reviewing dermatology residency applicants holistically

    Page :1038-1039

    Tatyana Koustov, Shannon Hanggodo, Kelley Sharp, Jane M. Grant-Kels

    
  • ·Ethical implications of aggressive treatment plans

    Page :1040-1041

    Ayushya Ajmani, Timothy Klufas, Kavin Kathir, Albert E. Zhou, Jane M. Grant-Kels

    
  • ·The ethics of teaching primary care physicians to perform skin biopsies

    Page :1042-1043

    Nidhi Kuchimanchi, Gabrielle Schwartzman, Barrett J. Zlotoff, Jane M. Grant-Kels

    
  • ·Ethical challenges of nonmedical switching and biosimilar substitution

    Page :1044-1045

    Melissa C. Leeolou, Justin L. Jia, Kavita Y. Sarin

    
  • ·Invisible hands: Ethical considerations of artificial intelligence use by medical students working with dermatologists

    Page :1046-1047

    Aarushi K. Parikh, Shari R. Lipner

    
  • ·Ethical implications of accelerated pathways for international medical graduates in residency training

    Page :1048-1049

    Ayushya Ajmani, Timothy Klufas, Albert E. Zhou, Sueheidi Santiago, Ektor Rafti, Jane M. Grant-Kels

    
  • ·Ethics of letters of intent in the residency application process

    Page :1050-1051

    James MacKenzie, Leah Kovacs, Albert E. Zhou, Jane M. Grant-Kels

    
  • ·Disclosure, donorship, and duty: The ethics of patient contributions

    Page :1052-1053

    Ayushya Ajmani, Albert E. Zhou, Jane M. Grant-Kels, Daniel M. Klufas

    
  • ·Is ignorance bliss? Ethical implications of parental refusal of biopsies in pediatric patients

    Page :1054-1055

    Timothy Klufas, Simran Saini, Albert E. Zhou, Maritza I. Perez, Jane M. Grant-Kels

     
  • ·Implementing artificial intelligence in pediatric dermatology: Balancing innovation and privacy when consent is revoked

    Page :1056-1057

    Omar Alani, Mahaa Ayub, Dev Patel, Samer Wahood, Jacob M. Appel

    

• JAAD Online

  • ·Between skin and psyche: Navigating mental health in the dermatology clinic

    Page :e147

    Grace Rabinowitz, Tracy Okine, Nicholas Gulati

    
  • ·Ethical considerations of unsolicited advice in the management of traction alopecia

    Page :e149

    Aarushi K. Parikh, Noelle Desir, Susan C. Taylor, Shari R. Lipner

    
  • ·Body politics

    Page :e151

    Marra Aghajani, Jessie Tong Lu, Deshan F. Sebaratnam

    
  • ·Ethics of multiple medical student away dermatology rotations

    Page :e153

    Sowmya Ravi, James Mackenzie, Albert E. Zhou, Jane M. Grant-Kels

    
  • ·Ethical concerns in inpatient dermatology: Managing complex patients with limited capacity

    Page :e155

    Ryan Chen, Vinod E. Nambudiri, Nutan Gowda

    
  • ·Ethics of partnerships between pharmaceutical and telehealth companies

    Page :e157

    Leah D. Kovacs, Albert Zhou, Jane M. Grant-Kels

    
  • ·Ethical implications of secret shopper calls in dermatologic research

    Page :e159

    Seda Sahin, Albert E. Zhou, Jane M. Grant-Kels

    
  • ·Navigating tensions when dermatologists change jobs: Who should manage biopsy results

    Page :e161

    Sowmya Ravi, Timothy Klufas, Albert E. Zhou, Maxwell A. Fung, Jane M. Grant-Kels

    
  • ·Ethics of caring for a patient who is rude to staff and medical trainees

    Page :e163

    Aaron D. Smith, Gabrielle Schwartzman, Jane M. Grant-Kels

    
  • ·Ethics of discussing illicit substance use and harm reduction in dermatologic care

    Page :e165

    Aaron D. Smith, Gabrielle Schwartzman, Catherine E. Lyons, Jane M. Grant-Kels

    
  • ·Botulinum toxin for gustatory hyperhidrosis

    Page :e167

    Nari Lee, Victoria Sharon

    Plan Plan  
  • ·Innovative use of elastic adhesive bandage for securing intravenous catheter used for ear piercing

    Page :e169

    Avanija Sai Gajula, Tirekha Suyamprakasam Vimala, Krishnaveni R, Sheetanshu Kumar

    Plan Plan  
  • ·A novel 3D-printed soft resin adapter enhances imaging consistency for reflection confocal microscopy of elevated lesions

    Page :e171

    Yifan Xie, Chengbei Bao, Qiuyun Xu, Zhen Liang, Ting Gong, Chao Ji

    Plan Plan  
  • ·Response to Teachout et al “Response to Ezzat et al, “Response to Rypka et al, ‘A single center retrospective cohort study of hydroxychloroquine-related adverse events in adults with lymphocytic cicatricial alopecia’”

    Page :e173

    Raymond Z. Ezzat, Maryanne M. Senna

    
  • ·A new dawn for vitamin D in psoriasis: Beyond bone health to cardiovascular resilience

    Page :e175

    Peizhi Deng, Jianyun Lu

    
  • ·Response to Deng et al, “A new dawn for vitamin D in psoriasis: Beyond bone health to cardiovascular resilience”

    Page :e177

    Ya Miao, Bin Zhao, Jiaqi Huang

    
  • ·Comment on “Patient-reported quality of life and aesthetic satisfaction continues to improve for 1-year after Mohs surgery: A multicenter prospective cohort study”

    Page :e179

    Detian Zhang, Dongcheng Xie, Wenbo Bu

    
  • ·Response to Zhang et al, Comment on “Patient-reported quality of life and aesthetic satisfaction continues to improve for 1-year after Mohs surgery: A multicenter prospective cohort study”

    Page :e181

    Inge J. Veldhuizen, Stephen W. Dusza, Erica H. Lee

    
  • ·Response to Childs et al., “The four ‘D’s of psoriasis disparities in patients with skin of color: A Letter to the Editor”

    Page :e183

    Marissa Joseph, Jeffrey Ding, Faisal Khosa

    
  • ·The 4 D’s of psoriasis disparities in patients with skin of color: A letter to the editor

    Page :e185

    Beth A. Childs, Arianna J. Zhang, Andrew F. Alexis, Joseph F. Merola

    Plan Plan  
  • ·Reassessing the role of obesity in melanoma stage and recurrence

    Page :e189

    Rong Sun, Deqi Kong

    
  • ·Response to Gronbeck et al’s “Dermatologic toxicities of antibody–drug conjugates”: Why ado-trastuzumab emtansine–associated telangiectasias deserve clinical attention

    Page :e191

    Andrea Michelerio, Carlo Tomasini, Valeria Brazzelli

    
  • ·Prior treatment clarity and safety imperatives in pediatric alopecia areata combination therapy

    Page :e193

    Zheying Huang, Jiwei Wu

    Plan Plan
  • ·Comments on Liu et al’s “Caged-hypocrellin mediated antimicrobial photodynamic therapy as a dual-action strategy for fungal clearance and immune response regulation in drug-resistant Candida auris wound infections”

    Page :e195

    Shiuan-Chih Chen, Yuan-Ti Lee

    
  • ·Reply to: “Comments on Liu et al’s ‘Caged-hypocrellin mediated antimicrobial photodynamic therapy as a dual-action strategy for fungal clearance and immune response regulation in drug-resistant Candida auris wound infections’”

    Page :e197

    Xinyao Liu, Shaohua Guo, Jiao Wang, Linwan Zhang, Yusong Lin, Yuzhou Liu, Jiangshan Ouyang, Dongmei Shi, Bin Xu, Wenjie Fang, Yuping Ran

    
  • ·Comment on “Effect of finger socks on clinical cure in interdigital tinea pedis”: Possible risk of chilblains in warm weather conditions

    Page :e199

    Pedro Gil-Pallares, Alba Navarro-Bielsa, Ignacio Hernández-Aragüés, Tamara Gracia-Cazaña, Yolanda Gilaberte

     
  • ·Response to Gil-Pallares et al, “Comment on “Effect of finger socks on clinical cure in interdigital tinea pedis”: Possible risk of chilblains in warm weather conditions”

    Page :e201

    Hasan Aksoy, Mehmet Salih Gürel

    
  • ·Pediatric longitudinal melanonychia: Why aggressive matrix grafting may be premature

    Page :e203

    Zhiyuan Zhu, Wei Hua, Siliang Xue

    
  • ·Response to Xue et al “Pediatric longitudinal melanonychia: Why aggressive matrix grafting may be premature”

    Page :e205

    Rong Zhou, Xiaofei Tian, Lin Qiu, Xionghui Ding, Yan Liu, Jun Xiao

     
  • ·Isotretinoin combined with oral tranexamic acid for moderate-to-severe acne vulgaris: Evidence gaps and future directions

    Page :e207

    Zhongyi Xu, Chengfeng Zhang

    
  • ·Response to Zhang et al, “Isotretinoin combined with oral tranexamic acid for moderate-to-severe acne vulgaris: Evidence gaps and future directions”

    Page :e209

    Bingyang Xu, Shengxiang Xiao, Jiawen Wu

    
  • ·Advancing skin organoids in dermatology: Current limitations and future horizons

    Page :e211

    Hui Sun, Wei Shen, Hua-Jie Zhong, Yu-Mei Li

    
  • ·Response to Sun et al, “Advancing skin organoids in dermatology: Current limitations and future horizons”

    Page :e213

    Diala Haykal

    
  • ·Response to Davis et al, “Focused update: Guidelines of care for the management of atopic dermatitis in adults”

    Page :e215

    Elena Hawryluk, Jenny E. Murase, Lindsy Frazer-Green

    Plan Plan
  • ·March 2026 IOTADERMA (#385)

    Page :e217

    Robert I. Rudolph